QMS Medical Allied Services (NSE:QMSMEDI) 3-Year EBITDA Growth Rate : 10.10% (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is QMS Medical Allied Services 3-Year EBITDA Growth Rate?

QMS Medical Allied Services's EBITDA per Share for the three months ended in Dec. 2023 was ₹2.80.

During the past 12 months, QMS Medical Allied Services's average EBITDA Per Share Growth Rate was 102.60% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 10.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 4 years, the highest 3-Year average EBITDA Per Share Growth Rate of QMS Medical Allied Services was 10.10% per year. The lowest was 10.10% per year. And the median was 10.10% per year.

Competitive Comparison of QMS Medical Allied Services's 3-Year EBITDA Growth Rate

For the Medical Instruments & Supplies subindustry, QMS Medical Allied Services's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

QMS Medical Allied Services's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, QMS Medical Allied Services's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where QMS Medical Allied Services's 3-Year EBITDA Growth Rate falls into.

QMS Medical Allied Services 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

QMS Medical Allied Services (NSE:QMSMEDI) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

QMS Medical Allied Services 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of QMS Medical Allied Services's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

QMS Medical Allied Services (NSE:QMSMEDI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » QMS Medical Allied Services Ltd (NSE:QMSMEDI) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Prabhat Colony, Road No. 3, 1A-B/2A-B, Navkala Bharti Building, Plot No. 16, Near Santacruz Bus Depot, Santacruz (East), Mumbai, MH, IND, 400055

Website

https://qmsmas.com

QMS Medical Allied Services Ltd is engaged in the marketing and distribution of a wide range of medical products as well as medical education services. The company's products are sold under brand name "QDevices" and also manage the distribution for other brands such as 3M, Heine, Rossmax and others. It offers medical products such as Blood Pressure Monitors, Glucose Monitoring Kits and strips, Dental Products, Personal protection kits eg-PPE kits, Infection prevention, Stethoscope and Oxygen Concentrator.

QMS Medical Allied Services (NSE:QMSMEDI) Headlines

No Headlines